Friday, February 15, 2013

JOIN THE CLINICAL TRIAL
A PHASE III OF ONARTUZUMAB (METMAB) WITH TARCEVA AGAINST TARCEVA ALONE FOR ADVANCED OR METASTATIC LUNG CANCER!
THIS IS A FIRST LINE TREATMENT
NCT01456325, OAM4971g

No comments: